|
Comparison of endpoints at six weeks expressed as changes from baseline. |
|||
| Treatment |
Placebo |
P value |
|
|
|
|||
| Total Cholesterol (mmol/L) |
-0.3 ± 0.1 *** |
-0.1 ± 0.08 |
0.184 |
| LDL cholesterol (mmol/L)** |
-0.3 ± 0.1 *** |
-0.04 ± 0.08 |
0.026 |
| HDL cholesterol (mmol/L) |
-0.02 ± 0.02 |
-0.009 ± 0.02 |
0.842 |
| Triglyceride (mmol/L)* |
0.09 ± 0.1 |
-0.2 ± 0.1*** |
0.030 |
| Cholesterol/HDL ratio |
-0.2 ± 0.1 |
-0.1 ± 0.1 |
0.947 |
| C-Reactive protein (mg/dL) |
-0.03 ± 0.06 |
0.01 ± 0.04 |
0.546 |
| Homocysteine (μM/L) |
0.4 ± 0.4 |
0.2 ± 0.2 |
0.528 |
| Insulin (pmol/L) |
6.9 ± 4.9 |
4.2 ± 10.4 |
0.804 |
| Glucose (mmol/L) |
0.2 ± 0.09 |
0.03 ± 0.09 |
0.259 |
| Weight (kg) |
-0.7 ± 0.3 |
1.4 ± 1.3 |
0.117 |
| Blood pressure (systolic/diastolic, mmHg, value at end point) |
119/69 ± 1.9/1.3 |
119/69 ± 2.0/1.7 |
0.832/0.856 |
| Total Energy Intake per day (kJ) |
-519 ± 330 |
-343 ± 360 |
0.724 |
| Carbohydrate intake (% of total) |
0.4 ± 2.0 |
1.8 ± 1.3 |
0.535 |
| Protein Intake (% of total) |
0.9 ± 0.6 |
-0.9 ± 1.1 |
0.041 |
| Fat Intake (% of total) |
-0.7 ± 1.8 |
-1.2 ± 1.1 |
0.784 |
| Dietary Fiber Intake (grams) |
-0.3 ± 1.1 |
-1.4 ± 1.6 |
0.454 |
|
Data are means ± SEM. ***Statistically different from baseline, within group comparison p < 0.05 | |||
Queenan et al. Nutrition Journal 2007 6:6 doi:10.1186/1475-2891-6-6 |
|||